Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
TOP STORIES — Diabetes News and Research
Gestational Diabetes Can Increase CVD Risk
ADA 81st Symposium: COVID-19 and New-Onset Type 2 Diabetes
MOST POPULAR ARTICLES OF THE MONTH
#1 Benefits for Patients with Type 1 Diabetes Using the New Omnipod® 5
Letter from the Editor
It was 1993 when I first started eating low carbohydrate. It wasn’t for diabetes but it was for weight loss. Using a low carbohydrate diet and adding soluble fiber and moderate exercise, I was able to drop from 286 to 180 in a 1 year period. I have stayed low carb for the past 28 years, with some straying, but my weight this morning was 181.5. There is no doubt in my mind that if I had not done this, I would likely have type 2 diabetes, hypertension, and maybe more problems.
Many of my patients have told me it is impossible for them to stay this way long term and that they won’t even try. Although it was very hard back in the 90’s, things have gotten a lot easier with the multitude of healthy low carb products available. But even with these additions, patients and prescribers feel it is hard to do.
This week our intern Torré Anderson, II, Doctor of Pharmacy Candidate, FAMU College of Pharmacy, took a look at a large study presented at the recent ADA scientific sessions, and has some interesting observations as to the real world difficulties of maintaining a low carb diet long term. This is likely a great article to print and hand to your patients who say cutting carbs is impossible.
*****************************
We can make a difference!
*****************************
Dave Joffe
Editor-in-chief
Newsflash: Once-weekly Bydureon BCise Approved for Ages 10-18
The FDA has approved once-weekly Bydureon BCise (exenatide) for patients 10 to 18 years old with T2D. The only other non-insulin options available for adolescents with diabetes are metformin and liraglutide, and they usually have to be taken daily.
GD history is linked with coronary artery calcification (CAC) in women, an indicator of atherosclerotic CVD, and a predictor of CVD clinical events.
We know the positive effects of carbohydrate restriction on glycemia, but what is the impact on quality of life and cognition?
How has the pandemic affected the incidence of type 2 diabetes and other conditions such as Hyperosmolar Hyperglycemic Syndrome (HHS) within the younger population?